Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

captopril-hydroCHLOROthiazide

captopril-hydroCHLOROthiazide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Capozide TABLET, ORAL 25 mg-15 mg, 25 mg-25 mg, 50 mg-15 mg, 50 mg-25 mg    
Comments:

Ordered Formulation

Therapeutic Interchange

captopril-hydroCHLOROthiazide (Capozide)                                                                  

  • 25 mg-15 mg tablet oral                                                                                                    
  • 50 mg-15 mg tablet oral

captopril (Capoten) AND hydroCHLOROthiazide (Microzide)

  • 25 mg captopril tablet PLUS ONE 12.5 mg hydroCHLOROthiazide capsule
  • 50 mg captopril tablet PLUS ONE 12.5 mg hydroCHLOROthiazide capsule

captopril-hydroCHLOROthiazide (Capozide)                                                                                      

  • 25 mg-25 mg tablet oral                                                                                        
  • 50 mg-25 mg tablet oral

captopril (Capoten) AND hydroCHLOROthiazide (HydroDIURIL)

  • 25 mg captopril tablet PLUS ONE 25 mg hydroCHLOROthiazide tablet
  • 50 mg captopril tablet PLUS ONE 25 mg hydroCHLOROthiazide tablet

Dispense each agent separately.

Doses of 15 mg of HCTZ will be converted to 12.5 mg

 Updated: 22 March 2016 (Capozide)

Last updated: Dec. 14, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved